Suppr超能文献

对用于医学和生物医学科学领域的预印本平台进行系统审查。

Systematic examination of preprint platforms for use in the medical and biomedical sciences setting.

作者信息

Kirkham Jamie J, Penfold Naomi C, Murphy Fiona, Boutron Isabelle, Ioannidis John P, Polka Jessica, Moher David

机构信息

Centre for Biostatistics, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK

ASAPbio, San Francisco, California, USA.

出版信息

BMJ Open. 2020 Dec 29;10(12):e041849. doi: 10.1136/bmjopen-2020-041849.

Abstract

OBJECTIVES

The objective of this review is to identify all preprint platforms with biomedical and medical scope and to compare and contrast the key characteristics and policies of these platforms.

STUDY DESIGN AND SETTING

Preprint platforms that were launched up to 25 June 2019 and have a biomedical and medical scope according to MEDLINE's journal selection criteria were identified using existing lists, web-based searches and the expertise of both academic and non-academic publication scientists. A data extraction form was developed, pilot tested and used to collect data from each preprint platform's webpage(s).

RESULTS

A total of 44 preprint platforms were identified as having biomedical and medical scope, 17 (39%) were hosted by the Open Science Framework preprint infrastructure, 6 (14%) were provided by F1000 Research (the Open Research Central infrastructure) and 21 (48%) were other independent preprint platforms. Preprint platforms were either owned by non-profit academic groups, scientific societies or funding organisations (n=28; 64%), owned/partly owned by for-profit publishers or companies (n=14; 32%) or owned by individuals/small communities (n=2; 5%). Twenty-four (55%) preprint platforms accepted content from all scientific fields although some of these had restrictions relating to funding source, geographical region or an affiliated journal's remit. Thirty-three (75%) preprint platforms provided details about article screening (basic checks) and 14 (32%) of these actively involved researchers with context expertise in the screening process. Almost all preprint platforms allow submission to any peer-reviewed journal following publication, have a preservation plan for read access and most have a policy regarding reasons for retraction and the sustainability of the service.

CONCLUSION

A large number of preprint platforms exist for use in biomedical and medical sciences, all of which offer researchers an opportunity to rapidly disseminate their research findings onto an open-access public server, subject to scope and eligibility.

摘要

目的

本综述的目的是识别所有涵盖生物医学和医学领域的预印本平台,并比较和对比这些平台的关键特征和政策。

研究设计与设置

根据MEDLINE的期刊选择标准,利用现有列表、网络搜索以及学术和非学术出版科学家的专业知识,识别出截至2019年6月25日推出的、涵盖生物医学和医学领域的预印本平台。开发了一份数据提取表,进行了预测试,并用于从每个预印本平台的网页收集数据。

结果

共识别出44个涵盖生物医学和医学领域的预印本平台,其中17个(39%)由开放科学框架预印本基础设施托管,6个(14%)由F1000 Research(开放研究中心基础设施)提供,21个(48%)是其他独立预印本平台。预印本平台要么由非营利学术团体、科学协会或资助组织所有(n = 28;64%),由营利性出版商或公司拥有/部分拥有(n = 14;32%),要么由个人/小团体拥有(n = 2;5%)。24个(55%)预印本平台接受所有科学领域的内容,尽管其中一些对资金来源、地理区域或附属期刊的范围有限制。33个(75%)预印本平台提供了文章筛选(基本检查)的详细信息,其中14个(32%)在筛选过程中积极邀请具有背景专业知识的研究人员参与。几乎所有预印本平台都允许在发表后提交给任何同行评审期刊,有一个用于读取访问的保存计划,并且大多数都有关于撤回原因和服务可持续性的政策。

结论

存在大量用于生物医学和医学科学的预印本平台,所有这些平台都为研究人员提供了一个机会,在符合范围和资格的前提下,将他们的研究结果迅速传播到开放获取的公共服务器上。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2ed/7778769/95cd2ccf0b68/bmjopen-2020-041849f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验